2024 ICD-10-CM Diagnosis Code C69.31

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

• Malignant melanoma of choroid
• Malignant melanoma of right choroid
• Malignant melanoma of uveal tract
• Malignant tumor of choroid
• Malignant tumor of choroid
• Primary malignant neoplasm of choroid
• Primary malignant neoplasm of uveal tract of eye
• Right choroidal primary malignant neoplasm

Clinical Information

• Choroid

  the thin, highly vascular membrane covering most of the posterior of the eye between the retina and sclera.

• Choroid Diseases

  disorders of the choroid including hereditary choroidal diseases, neoplasms, and other abnormalities of the vascular layer of the uvea.

• Choroid Hemorrhage

  hemorrhage from the vessels of the choroid.

• Choroid Neoplasms

  tumors of the choroid; most common intraocular tumors are malignant melanomas of the choroid. these usually occur after puberty and increase in incidence with advancing age. most malignant melanomas of the uveal tract develop from benign melanomas (nevi).

• Choroid Plexus

  a villous structure of tangled masses of blood vessels contained within the third, lateral, and fourth ventricles of the brain. it regulates part of the production and composition of cerebrospinal fluid.

• Choroid Plexus Neoplasms

  benign or malignant tumors which arise from the choroid plexus of the ventricles of the brain. papillomas (see papilloma, choroid plexus) and carcinomas are the most common histologic subtypes, and tend to seed throughout the ventricular and subarachnoid spaces. clinical features include headaches, ataxia and alterations of consciousness, primarily resulting from associated hydrocephalus. (from devita et al., cancer: principles and practice of oncology, 5th ed, p2072; j neurosurg 1998 mar;88(3):521-8)

• Choroidal Effusions

  finding of fluid accumulation between the choroid and the sclera.

• Choroidal Neovascularization

  a pathological process consisting of the formation of new blood vessels in the choroid.

• Choroideremia

  an x chromosome-linked abnormality characterized by atrophy of the choroid and degeneration of the retinal pigment epithelium causing night blindness.

• Choroiditis

  inflammation of the choroid.

• Multifocal Choroiditis

  a multifocal uveitis syndrome involving the retinal pigment epithelium and capillary layer of the choroid. it is characterized by chronic uveitis and multiple choroid lesions referred to as white dots, blurry vision, floaters, sensitivity to light, blind spots, and eye discomfort.

• Papilloma, Choroid Plexus

  a usually benign neoplasm that arises from the cuboidal epithelium of the choroid plexus and takes the form of an enlarged choroid plexus, which may be associated with oversecretion of csf. the tumor usually presents in the first decade of life with signs of increased intracranial pressure including headaches; ataxia; diplopia; and alterations of mental status. in children it is most common in the lateral ventricles and in adults it tends to arise in the fourth ventricle. malignant transformation to choroid plexus carcinomas may rarely occur. (adams et al., principles of neurology, 6th ed, p667; devita et al., cancer: principles and practice of oncology, 5th ed, p2072)

• Polypoidal Choroidal Vasculopathy

  a choroid neovascularization characterized by serosanguineous retinal pigment epithelial detachment and leakage of serous exudate sometimes associated with aneurysmal polypoidal lesions.

• White Dot Syndromes

  a group of idiopathic multifocal posterior uveitis syndromes involving the choroid; retinal pigment epithelium; and retina. they are characterized by multiple lesions of hypoautofluorescent dots in the fundus oculi and reduced visual acuity. several entities including birdshot chorioretinopathy are hla-a antigens serotype a29 positive.

C69.31 is grouped with Diagnostic Related Groups - MS-DRG Mapping

Diagnostic Related Groups (DRGs) are a classification system used to group together diagnosis codes for the purpose of reimbursement and healthcare management. DRGs are used to standardize the way hospitals and other providers are paid for inpatient services. In this system patients are grouped together based on their principal diagnosis in areas referred to as Major Diagnostic Categories (MDC). Once a patient is assigned a particular diagnostic category, providers receive a predetermined payment rate for the services rendered. This reimbursement rate is often fixed and is meant to cover the cost of care for that patient. Reimbursement is also affected by the relative weight of a diagnostic related group based on the severity of a patient's illness and the associated cost of care during hospitalization.

Diagnostic related groups encourage healthcare providers to focus on quality and efficiency in patient care while managing costs effectively. The diagnosis code is present in the following groups for version MS-DRG V41.0 applicable from 10/01/2023 through 09/30/2024.

MS-DRG	MS-DRG Title	MCD	Relative Weight
124	OTHER DISORDERS OF THE EYE WITH MCC OR THROMBOLYTIC AGENT	02	1.3219
125	OTHER DISORDERS OF THE EYE WITHOUT MCC	02	0.7975

The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.

Convert C69.31 to ICD-9-CM

• ICD-9-CM Code: 190.6 - Malign neopl choroid
  Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Table of Neoplasms

The parent code C69.3 of the current diagnosis code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Filter table of neoplasms:

Neoplasm, neoplastic	Malignant Primary	Malignant Secondary	CaInSitu	Benign	Uncertain Behavior	Unspecified Behavior
»Neoplasm, neoplastic   »choroid	C69.3	C79.49	D09.2	D31.3	D48.7	D49.81

Patient Education

Eye Cancer

Cancer of the eye is uncommon. It can affect the outer parts of the eye, such as the eyelid, which are made up of muscles, skin and nerves. If the cancer starts inside the eyeball it's called intraocular cancer. The most common intraocular cancers in adults are melanoma and lymphoma. The most common eye cancer in children is retinoblastoma, which starts in the cells of the retina. Cancer can also spread to the eye from other parts of the body.

Treatment for eye cancer varies by the type and by how advanced it is. It may include surgery, radiation therapy, freezing or heat therapy, or laser therapy.

[Learn More in MedlinePlus]

Intraocular (Uveal) Melanoma Treatment (PDQ®)

Learn about intraocular (eye) melanoma risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Code History

• FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
• FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
• FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
• FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
• FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
• FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
• FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
• FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
• FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.